Cargando…
Acid Sphingomyelinase Inhibition Stabilizes Hepatic Ceramide Content and Improves Hepatic Biotransformation Capacity in a Murine Model of Polymicrobial Sepsis
Liver dysfunction during sepsis is an independent risk factor leading to increased mortality rates. Specifically, dysregulation of hepatic biotransformation capacity, especially of the cytochrome P450 (CYP) system, represents an important distress factor during host response. The activity of the con...
Autores principales: | Chung, Ha-Yeun, Witt, C. Julius, Hurtado-Oliveros, Jorge, Wickel, Jonathan, Gräler, Markus H., Lupp, Amelie, Claus, Ralf A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214114/ https://www.ncbi.nlm.nih.gov/pubmed/30326559 http://dx.doi.org/10.3390/ijms19103163 |
Ejemplares similares
-
Acid Sphingomyelinase Inhibition Prevents Development of Sepsis Sequelae in the Murine Liver
por: Chung, Ha-Yeun, et al.
Publicado: (2017) -
Adjustment of Dysregulated Ceramide Metabolism in a Murine Model of Sepsis-Induced Cardiac Dysfunction
por: Chung, Ha-Yeun, et al.
Publicado: (2017) -
Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies
por: Abusukhun, Murad, et al.
Publicado: (2021) -
The acid sphingomyelinase/ceramide system in COVID-19
por: Kornhuber, Johannes, et al.
Publicado: (2021) -
The Role of the Vagus Nerve: Modulation of the Inflammatory Reaction in Murine Polymicrobial Sepsis
por: Kessler, Wolfram, et al.
Publicado: (2012)